WO2008078725A1 - チアゼピン誘導体 - Google Patents
チアゼピン誘導体 Download PDFInfo
- Publication number
- WO2008078725A1 WO2008078725A1 PCT/JP2007/074780 JP2007074780W WO2008078725A1 WO 2008078725 A1 WO2008078725 A1 WO 2008078725A1 JP 2007074780 W JP2007074780 W JP 2007074780W WO 2008078725 A1 WO2008078725 A1 WO 2008078725A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- substituent group
- independently selected
- substituents independently
- halogeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
本発明は、優れた11β-ヒドロキシステロイドデヒドロゲナーゼタイプ1阻害作用を有する一般式(I)で表されるチアゼピン誘導体又はその薬理上許容される塩に関する。[式中、R1は、水素原子、C1-C6アルキル基等;R2は、C1-C6アルキル基、C1-C6ハロゲン化アルキル基、C1-C6ヒドロキシアルキル基等;R3は、水素原子又はC1-C6アルキル基;R4は、置換基群aから選択される基で独立に1乃至5個置換されていてもよいC6-C10アリール基又は置換基群aから選択される基で独立に1乃至3個置換されていてもよい複素環基;置換基群aは、ハロゲン原子、C1-C6アルキル基、置換基群bから選択される基で独立に1乃至5個置換されていてもよいC6-C10アリール基等;置換基群bは、ハロゲン原子、C1-C6アルキル基、C1-C6ハロゲン化アルキル基等]
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008551103A JPWO2008078725A1 (ja) | 2006-12-26 | 2007-12-25 | チアゼピン誘導体 |
EP07860009A EP2119719A1 (en) | 2006-12-26 | 2007-12-25 | Thiazepine derivative |
US12/493,056 US20100004221A1 (en) | 2006-12-26 | 2009-06-26 | Thiazepine derivative |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006-348763 | 2006-12-26 | ||
JP2006348763 | 2006-12-26 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/493,056 Continuation US20100004221A1 (en) | 2006-12-26 | 2009-06-26 | Thiazepine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008078725A1 true WO2008078725A1 (ja) | 2008-07-03 |
Family
ID=39562514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/074780 WO2008078725A1 (ja) | 2006-12-26 | 2007-12-25 | チアゼピン誘導体 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100004221A1 (ja) |
EP (1) | EP2119719A1 (ja) |
JP (1) | JPWO2008078725A1 (ja) |
TW (1) | TW200835502A (ja) |
WO (1) | WO2008078725A1 (ja) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011007756A1 (ja) | 2009-07-13 | 2011-01-20 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
WO2011161030A1 (de) | 2010-06-21 | 2011-12-29 | Sanofi | Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren |
WO2012004270A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012004269A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012010413A1 (de) | 2010-07-05 | 2012-01-26 | Sanofi | Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012144478A1 (ja) | 2011-04-19 | 2012-10-26 | 第一三共株式会社 | テトラヒドロチアゼピン誘導体 |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2746277A1 (en) | 2012-12-19 | 2014-06-25 | Basf Se | Fungicidal imidazolyl and triazolyl compounds |
US8822699B2 (en) | 2010-09-02 | 2014-09-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI490214B (zh) | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為vap-1抑制劑之用途 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2796381A1 (fr) * | 1999-07-12 | 2001-01-19 | Hoechst Marion Roussel Inc | Derives bicycliques de thioazepine ou de caprolactame, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
US6521666B1 (en) | 1998-01-20 | 2003-02-18 | Tanabe Seiyaku Co., Ltd. | Inhibitors of α4 mediated cell adhesion |
WO2003065983A2 (en) | 2002-02-01 | 2003-08-14 | Merck & Co., Inc. | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
EP1445253A1 (en) | 2001-11-16 | 2004-08-11 | Yamanouchi Pharmaceutical Co. Ltd. | 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
WO2004089367A1 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Pharmaceutical use of substituted 1,2,4-triazoles |
WO2004089380A2 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Pharmaceutical use of fused 1,2,4-triazoles |
WO2005080397A2 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
JP2006502162A (ja) * | 2002-09-04 | 2006-01-19 | ブリストル−マイヤーズ スクイブ カンパニー | 成長ホルモン分泌促進剤として有用なヘテロ環状芳香族化合物 |
WO2006030805A1 (ja) * | 2004-09-16 | 2006-03-23 | Astellas Pharma Inc. | トリアゾール誘導体またはその塩 |
JP2006522750A (ja) * | 2003-04-11 | 2006-10-05 | ノボ ノルディスク アクティーゼルスカブ | 代謝性症候群ならびに関連の疾患および障害を治療するために、11β−ヒドロキシステロイドデヒドロゲナーゼ1型阻害剤および抗高血圧剤を使用する併用療法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7501405B2 (en) * | 2003-04-11 | 2009-03-10 | High Point Pharmaceuticals, Llc | Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders |
-
2007
- 2007-12-25 WO PCT/JP2007/074780 patent/WO2008078725A1/ja active Application Filing
- 2007-12-25 TW TW096149901A patent/TW200835502A/zh unknown
- 2007-12-25 JP JP2008551103A patent/JPWO2008078725A1/ja not_active Withdrawn
- 2007-12-25 EP EP07860009A patent/EP2119719A1/en not_active Withdrawn
-
2009
- 2009-06-26 US US12/493,056 patent/US20100004221A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6521666B1 (en) | 1998-01-20 | 2003-02-18 | Tanabe Seiyaku Co., Ltd. | Inhibitors of α4 mediated cell adhesion |
FR2796381A1 (fr) * | 1999-07-12 | 2001-01-19 | Hoechst Marion Roussel Inc | Derives bicycliques de thioazepine ou de caprolactame, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
EP1445253A1 (en) | 2001-11-16 | 2004-08-11 | Yamanouchi Pharmaceutical Co. Ltd. | 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
WO2003065983A2 (en) | 2002-02-01 | 2003-08-14 | Merck & Co., Inc. | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
JP2006502162A (ja) * | 2002-09-04 | 2006-01-19 | ブリストル−マイヤーズ スクイブ カンパニー | 成長ホルモン分泌促進剤として有用なヘテロ環状芳香族化合物 |
WO2004089367A1 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Pharmaceutical use of substituted 1,2,4-triazoles |
WO2004089380A2 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Pharmaceutical use of fused 1,2,4-triazoles |
JP2006522747A (ja) * | 2003-04-11 | 2006-10-05 | ノボ ノルディスク アクティーゼルスカブ | 縮合1,2,4−トリアゾールの薬学的使用 |
JP2006522750A (ja) * | 2003-04-11 | 2006-10-05 | ノボ ノルディスク アクティーゼルスカブ | 代謝性症候群ならびに関連の疾患および障害を治療するために、11β−ヒドロキシステロイドデヒドロゲナーゼ1型阻害剤および抗高血圧剤を使用する併用療法 |
WO2005080397A2 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
WO2006030805A1 (ja) * | 2004-09-16 | 2006-03-23 | Astellas Pharma Inc. | トリアゾール誘導体またはその塩 |
Non-Patent Citations (13)
Title |
---|
BIOORG. MED. CHEM. LETT., vol. 15, 2005, pages 1863 - 1865 |
ENDOCRINOLOGY, vol. 142, 2001, pages 1371 |
J. MED. CHEM., vol. 43, 2000, pages 4388 - 4397 |
J. ORG. CHEM., vol. 68, 2003, pages 2030 - 2033 |
JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, 2002, pages 3813 |
NATURE, vol. 414, 2001, pages 782 |
SCIENCE, vol. 294, 2001, pages 2166 |
T. W. GREENE ET AL.: "Protective Groups in Organic Synthesis", 1999, JOHN WILEY & SONS, INC. |
THE AMERICAN JOURNAL OF MEDICINE, vol. 108, 2000, pages 23 |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 89, 2004, pages 2601 |
THE JOURNAL OF CLINICAL INVESTIGATION, vol. 112, 2003, pages 83 |
THE LANCET, vol. 365, 2005, pages 1415 |
THEODORA W. GREENE; PETER G. M. WUTS: "Protective Groups in Organic Synthesis", 1999, A WILEY-INTERSCIENCE PUBLICATION |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011007756A1 (ja) | 2009-07-13 | 2011-01-20 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
WO2011161030A1 (de) | 2010-06-21 | 2011-12-29 | Sanofi | Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren |
WO2012010413A1 (de) | 2010-07-05 | 2012-01-26 | Sanofi | Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012004269A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
WO2012004270A1 (de) | 2010-07-05 | 2012-01-12 | Sanofi | Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US8822699B2 (en) | 2010-09-02 | 2014-09-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
US8901309B2 (en) | 2010-09-02 | 2014-12-02 | Takeda Pharmaceutical Company Limited | Fused triazoles for the treatment or prophylaxis of mild cognitive impairment |
WO2012144478A1 (ja) | 2011-04-19 | 2012-10-26 | 第一三共株式会社 | テトラヒドロチアゼピン誘導体 |
US8927536B2 (en) | 2011-04-19 | 2015-01-06 | Daiichi Sankyo Company, Limited | Tetrahydrothiazepine derivative |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2746277A1 (en) | 2012-12-19 | 2014-06-25 | Basf Se | Fungicidal imidazolyl and triazolyl compounds |
Also Published As
Publication number | Publication date |
---|---|
EP2119719A1 (en) | 2009-11-18 |
JPWO2008078725A1 (ja) | 2010-04-30 |
US20100004221A1 (en) | 2010-01-07 |
TW200835502A (en) | 2008-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008078725A1 (ja) | チアゼピン誘導体 | |
TW200606137A (en) | Urea derivatives | |
EP1700856A4 (en) | thiazole | |
EP1921077A4 (en) | AGENT FOR THE TREATMENT AND / OR PREVENTION OF SLEEP DISORDERS | |
WO2008111441A1 (ja) | 医薬組成物 | |
WO2008105058A1 (ja) | スルホンアミド化合物 | |
WO2008093674A1 (ja) | キナーゼ阻害活性を有する新規チアジアゾール誘導体 | |
EP1541559A4 (en) | 5-SUBSTITUTED ISOQUINOLINE DERIVATIVE | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
WO2008120759A1 (ja) | ウレア化合物およびその用途 | |
WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
WO2008114819A1 (ja) | 新規アデニン化合物 | |
WO2008123469A1 (ja) | 6員環アミド化合物およびその用途 | |
TW200745034A (en) | New compounds | |
TW200616994A (en) | Novel thiophene derivatives | |
EP1845081A4 (en) | amide | |
EP1726584A4 (en) | 2-AMINOCHINAZOLINDERIVAT | |
WO2008140099A1 (ja) | テトラゾイルオキシム誘導体および植物病害防除剤 | |
MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
WO2008057775A3 (en) | Heterocyclic amide compounds useful as kinase inhibitors | |
EP1854789A4 (en) | CHINAZOLINE DERIVATIVE WITH TYROSINE KINASE HEMMENDER EFFECT | |
TW200728298A (en) | Thiophene compounds and thrombopoietin receptor activators | |
WO2008114812A1 (ja) | Jak阻害剤 | |
NO20072753L (no) | 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer | |
WO2008105526A1 (ja) | マクロ環状化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07860009 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008551103 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007860009 Country of ref document: EP |